<p>Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome</p>
نویسندگان
چکیده
منابع مشابه
Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases
Despite the efficacy of antidepressants such as amitriptyline for alleviating burning mouth syndrome (BMS) [1,2], BMS may persist after antidepressant monotherapy. However, recent case reports have shown that aripiprazole (APZ) augmentation can reduce chronic pain resistant to other treatments [3]. Herein, we present two cases in which patients with BMS responded well to a very low dose of APZ ...
متن کاملLow-dose aripiprazole for refractory burning mouth syndrome
We report a case of refractory burning mouth syndrome (BMS) ameliorated with low dose of aripiprazole. The patient was a 66-year-old female who had suffered from chronic burning pain in her tongue for 13 months. No abnormality associated with the burning sensation was detected in the laboratory tests and the oral findings. Considering the clinical feature and the history together, we diagnosed ...
متن کاملCharacteristics of middle-aged and older patients with temporomandibular disorders and burning mouth syndrome.
The aim of this study was to evaluate the relationship between pain intensities and psychosocial characteristics in middle-aged and older patients with temporomandibular disorders (TMDs) and burning mouth syndrome (BMS). Subjects were selected according to the Research Diagnostic Criteria for TMD (n = 705) and International Association for the Study of Pain criteria for BMS (n = 175). Patients ...
متن کاملGroup cognitive-behavioral intervention for patients with burning mouth syndrome.
This study was conducted to assess the psychological characteristics of, and determine the effectiveness of group cognitive-behavioral (CB) treatment for, patients with burning mouth syndrome (BMS). The baseline characteristics of 24 female patients (age 69.7 ± 5.9 years) and an identical number of healthy female control subjects (age 69.2 ± 5.5 years) were compared. The patient group had signi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuropsychiatric Disease and Treatment
سال: 2019
ISSN: 1178-2021
DOI: 10.2147/ndt.s235669